InsiderClue
← All stocks

Stoke Therapeutics, Inc.

STOK Net selling
CIK 0001623526 #2049 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$816.92K
$170.06K on a plan · $0.00 straight out of an exercise
Sold at will
$646.86K
6 of 8 sales
Net
−$816.92K
−$646.86K against sales at will

By person

9 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kaye Edward M. MD
Director
—
$402.53K (2)
−$402.53K
124,557
0.1930%
$3.87M
+365.6%
Ticho Barry
CHIEF MEDICAL OFFICER
—
$322.75K (4) scheduled
−$322.75K
20,110
0.0312%
$624.55K
+709.3%
Allan Jonathan
GENERAL COUNSEL & CORP SEC
—
$91.64K (2)
−$91.64K
21,225
0.0329%
$659.18K
+167.4%
Skorpios Trust entity
10% owner
—
—
—
3,906,181
6.05%
$121.31M
−64.0%
Krainer Adrian R.
Director
—
—
—
283,302
0.4390%
$8.80M
−30.0%
TZIANABOS ARTHUR
Director
—
—
—
31,339
0.0486%
$973.29K
−1.3%
Hoitt Jason
Chief Patient Officer
—
—
—
10,276
0.0159%
$319.14K
+157.7%
Leggett Thomas
Chief Financial Officer
—
—
—
10,172
0.0158%
$315.91K
—
LEVIN ARTHUR A
Director
—
—
—
4,237
0.0066%
$131.59K
—

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Ticho Barry
1 Sep 2026
CHIEF MEDICAL OFFICER
Sold on a plan
1,600
$31.06
$49.69K
Ticho Barry
1 Sep 2026
CHIEF MEDICAL OFFICER
Sold on a plan
3,945
$30.51
$120.37K
Allan Jonathan
18 Aug 2026
GENERAL COUNSEL & CORP SEC
Sell
145
$32.47
$4.71K
Allan Jonathan
18 Aug 2026
GENERAL COUNSEL & CORP SEC
Sell
2,716
$32.01
$86.93K
Kaye Edward M. MD
18 Aug 2026
Director
Sell
637
$32.47
$20.68K
Kaye Edward M. MD
18 Aug 2026
Director
Sell
11,930
$32.01
$381.85K
Ticho Barry
18 Aug 2026
CHIEF MEDICAL OFFICER
Sell
242
$32.47
$7.86K
Ticho Barry
18 Aug 2026
CHIEF MEDICAL OFFICER
Sell
4,525
$32.01
$144.83K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 0
History held since 20 Jun 2019